{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:45:11Z","timestamp":1793781911828,"version":"4.6.1"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T00:00:00Z","timestamp":1680912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ypmed.2023.107489","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T10:56:01Z","timestamp":1680864961000},"page":"107489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Peripheral arterial disease (PAD) \u2013 A challenging manifestation of atherosclerosis"],"prefix":"10.1016","volume":"171","author":[{"given":"J.","family":"Nordanstig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.","family":"Behrendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.W.","family":"Bradbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.J.","family":"de Borst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FGR","family":"Fowkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Golledge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gottsater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Hinchliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nikol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Norgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ypmed.2023.107489_bb0005","doi-asserted-by":"crossref","first-page":"809","DOI":"10.5551\/jat.53660","article-title":"Asia-Pacific consensus statement on the Management of Peripheral Artery Disease: a report from the Asian pacific society of atherosclerosis and vascular disease Asia-Pacific peripheral artery disease consensus statement project Committee","volume":"27","author":"Abola","year":"2020","journal-title":"J. Atheroscler. Thromb."},{"issue":"24","key":"10.1016\/j.ypmed.2023.107489_bb0010","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1161\/CIR.0b013e318276fbcb","article-title":"Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association","volume":"126","author":"Aboyans","year":"2012","journal-title":"Circulation."},{"issue":"11","key":"10.1016\/j.ypmed.2023.107489_bb0015","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.5603\/KP.2017.0216","article-title":"2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)","volume":"75","author":"Aboyans","year":"2017","journal-title":"Kardiol. Pol."},{"issue":"3","key":"10.1016\/j.ypmed.2023.107489_bb0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejvs.2017.07.018","article-title":"Editor\u2019s choice - 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)","volume":"55","author":"Aboyans","year":"2018","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"1","key":"10.1016\/j.ypmed.2023.107489_bb0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clnu.2021.11.005","article-title":"The impact of nutrition on the development and progression of peripheral artery disease: a systematic review","volume":"41","author":"Adegbola","year":"2022","journal-title":"Clin. Nutr."},{"issue":"4","key":"10.1016\/j.ypmed.2023.107489_bb0030","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.amepre.2006.12.010","article-title":"Ethnic-specific prevalence of peripheral arterial disease in the United States","volume":"32","author":"Allison","year":"2007","journal-title":"Am. J. Prev. Med."},{"issue":"9","key":"10.1016\/j.ypmed.2023.107489_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073722","article-title":"Characterization of mesenchymal stem cells of \u201cno-options\u201d patients with critical limb ischemia treated by autologous bone marrow mononuclear cells","volume":"8","author":"Altaner","year":"2013","journal-title":"PLoS One"},{"issue":"10117","key":"10.1016\/j.ypmed.2023.107489_bb0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet."},{"issue":"24","key":"10.1016\/j.ypmed.2023.107489_bb0045","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence","volume":"376","author":"Armstrong","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.ypmed.2023.107489_bb0050","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1016\/j.jacc.2018.10.027","article-title":"2018 ACC expert consensus decision pathway on tobacco cessation treatment: a report of the American College of Cardiology Task Force on clinical expert consensus documents","volume":"72","author":"Barua","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.ypmed.2023.107489_bb0055","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1161\/CIRCRESAHA.121.318261","article-title":"Advances in revascularization for peripheral artery disease: revascularization in PAD","volume":"128","author":"Beckman","year":"2021","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.ypmed.2023.107489_bb0060","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jvs.2010.04.027","article-title":"Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial","volume":"52","author":"Belch","year":"2010","journal-title":"J. Vasc. Surg."},{"issue":"9781","key":"10.1016\/j.ypmed.2023.107489_bb0065","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(11)60394-2","article-title":"Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia","volume":"377","author":"Belch","year":"2011","journal-title":"Lancet."},{"issue":"5","key":"10.1016\/j.ypmed.2023.107489_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052335","article-title":"Current status of Angiogenic cell therapy and related strategies applied in critical limb ischemia","volume":"22","author":"Beltran-Camacho","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ypmed.2023.107489_bb0075","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3727\/096368912X636777","article-title":"Safety and efficacy of autologous cell therapy in critical limb ischemia: a systematic review","volume":"22","author":"Benoit","year":"2013","journal-title":"Cell Transplant."},{"issue":"21","key":"10.1016\/j.ypmed.2023.107489_bb0080","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.ypmed.2023.107489_bb0085","doi-asserted-by":"crossref","DOI":"10.3310\/hta14140","volume":"14","author":"Bradbury","year":"2010","journal-title":"Health Technol. Assess."},{"issue":"1","key":"10.1016\/j.ypmed.2023.107489_bb0090","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-041715","article-title":"Platelet aggregation inhibitor prescription for newly diagnosed peripheral arterial disease in the Netherlands: a cohort study","volume":"11","author":"Brand","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.ypmed.2023.107489_bb0095","article-title":"Cilostazol for intermittent claudication","volume":"6","author":"Brown","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"9038","key":"10.1016\/j.ypmed.2023.107489_bb0100","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","author":"Committee","year":"1996","journal-title":"Lancet"},{"issue":"1S","key":"10.1016\/j.ypmed.2023.107489_bb0105","article-title":"Global vascular guidelines on the Management of Chronic Limb-Threatening Ischemia","volume":"58","author":"Conte","year":"2019","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"6S","key":"10.1016\/j.ypmed.2023.107489_bb0110","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J. Vasc. Surg."},{"issue":"2","key":"10.1016\/j.ypmed.2023.107489_bb0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.ypmed.2023.107489_bb0120","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui","year":"2015","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.ypmed.2023.107489_bb0125","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00268-012-1892-6","article-title":"Intra-arterial allogeneic mesenchymal stem cells for critical limb ischemia are safe and efficacious: report of a phase I study","volume":"37","author":"Das","year":"2013","journal-title":"World J. Surg."},{"issue":"25","key":"10.1016\/j.ypmed.2023.107489_bb0130","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa2207899","article-title":"Surgery or endovascular therapy for chronic limb-threatening ischemia","volume":"387","author":"Farber","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"9901","key":"10.1016\/j.ypmed.2023.107489_bb0135","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet."},{"issue":"3","key":"10.1016\/j.ypmed.2023.107489_bb0140","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrcardio.2016.179","article-title":"Peripheral artery disease: epidemiology and global perspectives","volume":"14","author":"Fowkes","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"issue":"Suppl. 102","key":"10.1016\/j.ypmed.2023.107489_bb0145","first-page":"1","article-title":"ESVM guideline on peripheral arterial disease","volume":"48","author":"Frank","year":"2019","journal-title":"Vasa."},{"issue":"1","key":"10.1016\/j.ypmed.2023.107489_bb0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jvs.2007.02.037","article-title":"Exercise performance in patients with peripheral arterial disease who have different types of exertional leg pain","volume":"46","author":"Gardner","year":"2007","journal-title":"J. Vasc. Surg."},{"issue":"12","key":"10.1016\/j.ypmed.2023.107489_bb0155","first-page":"e726","article-title":"2016 AHA\/ACC guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation."},{"issue":"7","key":"10.1016\/j.ypmed.2023.107489_bb0160","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/s41569-021-00663-9","article-title":"Update on the pathophysiology and medical treatment of peripheral artery disease","volume":"19","author":"Golledge","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ypmed.2023.107489_bb0165","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1479-5876-11-143","article-title":"A double blind randomized placebo controlled phase I\/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia","volume":"11","author":"Gupta","year":"2013","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.ypmed.2023.107489_bb0170","doi-asserted-by":"crossref","first-page":"689","DOI":"10.5966\/sctm.2016-0237","article-title":"Administration of Adult Human Bone Marrow-Derived, cultured, pooled, allogeneic mesenchymal stromal cells in critical limb ischemia due to Buerger\u2019s disease: phase II study report suggests clinical efficacy","volume":"6","author":"Gupta","year":"2017","journal-title":"Stem Cells Transl. Med."},{"issue":"3","key":"10.1016\/j.ypmed.2023.107489_bb0175","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/bjs.10657","article-title":"Cardiovascular and all-cause mortality in patients with intermittent claudication and critical limb ischaemia","volume":"105","author":"van Haelst","year":"2018","journal-title":"Br. J. Surg."},{"issue":"5","key":"10.1016\/j.ypmed.2023.107489_bb0180","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1024\/0301-1526\/a000298","article-title":"Gene therapy for therapeutic angiogenesis in peripheral arterial disease - a systematic review and meta-analysis of randomized, controlled trials","volume":"42","author":"Hammer","year":"2013","journal-title":"Vasa."},{"issue":"4","key":"10.1016\/j.ypmed.2023.107489_bb0185","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0034-1393976","article-title":"Overview of classification systems in peripheral artery disease","volume":"31","author":"Hardman","year":"2014","journal-title":"Semin. Interv. Radiol."},{"issue":"1","key":"10.1016\/j.ypmed.2023.107489_bb0190","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2006.03.011","article-title":"Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review","volume":"189","author":"Heald","year":"2006","journal-title":"Atherosclerosis."},{"issue":"7","key":"10.1016\/j.ypmed.2023.107489_bb0195","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJMoa022287","article-title":"Circulating endothelial progenitor cells, vascular function, and cardiovascular risk","volume":"348","author":"Hill","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ypmed.2023.107489_bb0200","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"JAMA."},{"issue":"1","key":"10.1016\/j.ypmed.2023.107489_bb0205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jvs.2013.03.044","article-title":"The toe-brachial index in the diagnosis of peripheral arterial disease","volume":"58","author":"Hoyer","year":"2013","journal-title":"J. Vasc. Surg."},{"issue":"1","key":"10.1016\/j.ypmed.2023.107489_bb0220","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13063-017-1968-6","article-title":"BAlloon versus stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial","volume":"18","author":"Hunt","year":"2017","journal-title":"Trials."},{"issue":"4","key":"10.1016\/j.ypmed.2023.107489_bb0225","first-page":"611","volume":"86","author":"Jaff","year":"2015","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"4","key":"10.1016\/j.ypmed.2023.107489_bb0230","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jvs.2018.10.069","article-title":"A systematic review and meta-analysis of the effects of supervised exercise therapy on modifiable cardiovascular risk factors in intermittent claudication","volume":"69","author":"Jansen","year":"2019","journal-title":"J. Vasc. Surg."},{"issue":"8","key":"10.1016\/j.ypmed.2023.107489_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135692","article-title":"Comparative efficacy and safety of different antiplatelet agents for prevention of major cardiovascular events and leg amputations in patients with peripheral arterial disease: a systematic review and network meta-analysis","volume":"10","author":"Katsanos","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ypmed.2023.107489_bb0240","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1634\/stemcells.2005-0365","article-title":"Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger\u2019s disease and ischemic limb disease animal model","volume":"24","author":"Kim","year":"2006","journal-title":"Stem Cells"},{"issue":"8","key":"10.1016\/j.ypmed.2023.107489_bb0245","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/s41591-019-0492-5","article-title":"Genome-wide association study of peripheral artery disease in the million veteran program","volume":"25","author":"Klarin","year":"2019","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.ypmed.2023.107489_bb0250","doi-asserted-by":"crossref","first-page":"11294","DOI":"10.3390\/ijms160511294","article-title":"A review of the pathophysiology and potential biomarkers for peripheral artery disease","volume":"16","author":"Krishna","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ypmed.2023.107489_bb0255","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMcp1507631","article-title":"Clinical practice. Peripheral artery disease","volume":"374","author":"Kullo","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ypmed.2023.107489_bb0260","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.diabres.2010.12.010","article-title":"Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial","volume":"92","author":"Lu","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.ypmed.2023.107489_bb0265","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.ypmed.2023.107489_bb0270","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archinte.159.4.387","article-title":"Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease","volume":"159","author":"McDermott","year":"1999","journal-title":"Arch. Intern. Med."},{"issue":"13","key":"10.1016\/j.ypmed.2023.107489_bb0275","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1001\/jama.286.13.1599","article-title":"Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment","volume":"286","author":"McDermott","year":"2001","journal-title":"JAMA."},{"issue":"7","key":"10.1016\/j.ypmed.2023.107489_bb0280","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1532-5415.2010.02941.x","article-title":"Leg symptom categories and rates of mobility decline in peripheral arterial disease","volume":"58","author":"McDermott","year":"2010","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1","key":"10.1016\/j.ypmed.2023.107489_bb0285","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/CIRCULATIONAHA.114.007002","article-title":"Six-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease","volume":"130","author":"McDermott","year":"2014","journal-title":"Circulation."},{"issue":"11","key":"10.1016\/j.ypmed.2023.107489_bb0290","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/ATVBAHA.120.313831","article-title":"Skeletal muscle pathology in peripheral artery disease: a brief review","volume":"40","author":"McDermott","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.ypmed.2023.107489_bb0295","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a Meta-analysis","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiol."},{"issue":"2","key":"10.1016\/j.ypmed.2023.107489_bb0300","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jvs.2018.08.156","article-title":"BEST-CLI trial on the homestretch","volume":"69","author":"Mills","year":"2019","journal-title":"J. Vasc. Surg."},{"issue":"9","key":"10.1016\/j.ypmed.2023.107489_bb0305","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/ATVBAHA.119.312864","article-title":"Pathologic disparities between peripheral artery disease and coronary artery disease","volume":"40","author":"Narula","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.ypmed.2023.107489_bb0310","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ypmed.2023.107489_bb0315","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jvs.2014.03.290","article-title":"Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population","volume":"60","author":"Nehler","year":"2014","journal-title":"J. Vasc. Surg."},{"issue":"5","key":"10.1016\/j.ypmed.2023.107489_bb0320","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/mt.2008.33","article-title":"Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia","volume":"16","author":"Nikol","year":"2008","journal-title":"Mol. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.ypmed.2023.107489_bb0325","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter-society consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"33","author":"Norgren","year":"2007","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"4","key":"10.1016\/j.ypmed.2023.107489_bb0330","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ejvs.2018.11.008","article-title":"PLX-PAD cell treatment of critical limb Ischaemia: rationale and design of the PACE trial","volume":"57","author":"Norgren","year":"2019","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"47","key":"10.1016\/j.ypmed.2023.107489_bb0335","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1093\/eurheartj\/ehab604","article-title":"Effect of evolocumab on acute arterial events across all vascular territories\u202f: results from the FOURIER trial","volume":"42","author":"Oyama","year":"2021","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ypmed.2023.107489_bb0340","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ejvs.2015.08.018","article-title":"Bone marrow derived cell therapy in critical limb ischemia: a meta-analysis of randomized placebo controlled trials","volume":"50","author":"Peeters Weem","year":"2015","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"7","key":"10.1016\/j.ypmed.2023.107489_bb0345","first-page":"1060","article-title":"A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia","volume":"78","author":"Perin","year":"2011","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ypmed.2023.107489_bb0350","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13063-015-1114-2","article-title":"Bypass versus angio plasty in severe ischaemia of the leg - 2 (BASIL-2) trial: study protocol for a randomised controlled trial","volume":"17","author":"Popplewell","year":"2016","journal-title":"Trials."},{"issue":"1","key":"10.1016\/j.ypmed.2023.107489_bb0355","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00125-006-0491-1","article-title":"High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study","volume":"50","author":"Prompers","year":"2007","journal-title":"Diabetologia."},{"issue":"6","key":"10.1016\/j.ypmed.2023.107489_bb0360","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jacc.2015.11.052","article-title":"Statins for prevention of cardiovascular events in a low-risk population with low ankle brachial index","volume":"67","author":"Ramos","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ypmed.2023.107489_bb0365","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","article-title":"Recommended standards for reports dealing with lower extremity ischemia: revised version","volume":"26","author":"Rutherford","year":"1997","journal-title":"J. Vasc. Surg."},{"issue":"10","key":"10.1016\/j.ypmed.2023.107489_bb0370","first-page":"3160","article-title":"Association between peripheral arterial disease and cardiovascular risk factors: role of ultrasonography versus ankle-brachial index","volume":"22","author":"Santoro","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.ypmed.2023.107489_bb0375","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/1358863X13480001","article-title":"Methods of symptom evaluation and their impact on peripheral artery disease (PAD) symptom prevalence: a review","volume":"18","author":"Schorr","year":"2013","journal-title":"Vasc. Med."},{"key":"10.1016\/j.ypmed.2023.107489_bb0380","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.avsg.2021.06.025","article-title":"A systematic review of exercise prescription in patients with intermittent claudication: does pain matter?","volume":"77","author":"Seed","year":"2021","journal-title":"Ann. Vasc. Surg."},{"issue":"6","key":"10.1016\/j.ypmed.2023.107489_bb0385","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jvs.2007.02.004","article-title":"A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences","volume":"45","author":"Sigvant","year":"2007","journal-title":"J. Vasc. Surg."},{"issue":"1","key":"10.1016\/j.ypmed.2023.107489_bb0390","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12872-018-0835-z","article-title":"Presentation and outcomes of indigenous Australians with peripheral artery disease","volume":"18","author":"Singh","year":"2018","journal-title":"BMC Cardiovasc. Disord."},{"issue":"8","key":"10.1016\/j.ypmed.2023.107489_bb0395","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis","volume":"7","author":"Song","year":"2019","journal-title":"Lancet Glob. Health"},{"issue":"2","key":"10.1016\/j.ypmed.2023.107489_bb0400","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/ije\/25.2.282","article-title":"The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease","volume":"25","author":"Stoffers","year":"1996","journal-title":"Int. J. Epidemiol."},{"issue":"9331","key":"10.1016\/j.ypmed.2023.107489_bb0405","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","article-title":"Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial","volume":"360","author":"Tateishi-Yuyama","year":"2002","journal-title":"Lancet."},{"issue":"6","key":"10.1016\/j.ypmed.2023.107489_bb0410","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e3182854cf1","article-title":"Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials","volume":"258","author":"Teraa","year":"2013","journal-title":"Ann. Surg."},{"issue":"1","key":"10.1016\/j.ypmed.2023.107489_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055592","article-title":"Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients","volume":"8","author":"Teraa","year":"2013","journal-title":"PLoS One"},{"issue":"33","key":"10.1016\/j.ypmed.2023.107489_bb0420","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ypmed.2023.107489_bb0425","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jvs.2004.08.049","article-title":"Influence of smoking on incidence and prevalence of peripheral arterial disease","volume":"40","author":"Willigendael","year":"2004","journal-title":"J. Vasc. Surg."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743523000695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743523000695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:18:09Z","timestamp":1758795489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743523000695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":83,"alternative-id":["S0091743523000695"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2023.107489","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral arterial disease (PAD) \u2013 A challenging manifestation of atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2023.107489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107489"}}